Use filters to refine the search results.
Results 1-4 of 4
|4-Jun-2015||DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through Notch hyper-activation||Faronato, M; Nguyen, VTM; Patten, DK; Lombardo, Y; Steel, JH, et al|
|28-Aug-2015||Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer||Lin, M-L; Patel, H; Remenyi, J; Banerji, CRS; Lai, C-F, et al|
|27-Nov-2015||Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion||Nguyen, VTM; Barozzi, I; Faronato, M; Lombardo, Y; Steel, JH, et al|
|15-Jun-2015||The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.||Magnani, L; Patten, DK; Nguyen, VTM; Hong, SP; Steel, JH, et al|